HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Scopio Labs Closes $16 Million Series B Round to Expand Commercial Rollout of Automated Microscopy Solutions
The company is propelling microscopy into the digital age. Its platform automates the imaging of full microscopy samples into uniquely high-resolution digital scans using cutting-edge computational photography techniques.
RefleXion Medical Raises $100 Million
RefleXion Medical said existing investors include, TPG’s The Rise Fund, KCK Group, Sofinnova Partners, Venrock, T. Rowe Price, and global pharmaceutical leaders, Pfizer Ventures and Johnson & Johnson Innovation, JJDC Inc., all participated in the round.
MicroPort CardioFlow Completes Raising New Round of Funds
The introduction of 7 prominent strategic investors, who are CPE, Hillhouse Capital Management, Ltd., Lake Bleu Capital, Gamnat, China Reform Conson Soochow Overseas Fund I L.P., Gortune Artemis Limited, and 3H Health Investment Fund I, L.P., raised approximately US$130 million reports MicroPort CardioFlow.
VIDA Diagnostics Completes Second Close Of Round C Financing
This investment augments an $11M investment round last month led by First Analysis Corporation and will further fuel the development and commercialization of VIDA Diagnostics innovative solutions to impact patient care for both traditional respiratory diseases as well as emergent COVID-19 conditions.
Perspectum Closes $36M Financing Round
Perspectum funding will drive the commercialization of LiverMultiScan® for clinical use, expand the CRO business as well as develop additional products for biliary disease, diabetes and cancer for both clinical and CRO applications.
54gene Closes $15M Series A
54gene notes the round included participation from Raba Capital, V8 Capital, Ingressive Capital, and follow on investment from Y Combinator, Better Ventures, Fifty Years, KdT Ventures, Aera VC and Pioneer Fund.
Halo Labs Closed a $12M Series B1 Financing Round led by Research Corporation Technologies
In addition, Halo Labs is actively looking at acquiring complementary technologies and companies to expand into the analytical particle space.
ShiraTronics, Inc. Completes $3 Million Additional Series A Financing
Financing was provided by Breakout Ventures (BOV). BOV joins previous Series A lead investors USVP, Amzak Health, and Strategic HealthCare Investment Partners (S.H.I.P), with participation from Aperture Ventures, LivaNova PLC, and a leading Academic Institution.
RubiconMD Secures $18M in Series C Financing Led by Deerfield Management Company
To date, RubiconMD has raised more than $40 million.
